NeoGenomics, Inc. Excess Tax Benefit from Share-based Compensation, Operating Activities
NeoGenomics, Inc. (NEO) reported Excess Tax Benefit from Share-based Compensation, Operating Activities of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-13.
Discontinued › Notes › Compensation Related Costs
us-gaap:ExcessTaxBenefitFromShareBasedCompensationOperatingActivities · last filed 2018-03-13
- NeoGenomics, Inc. excess tax benefit from share-based compensation, operating activities for fiscal 2017 was $0.00.
- NeoGenomics, Inc. excess tax benefit from share-based compensation, operating activities for fiscal 2016 was $0.00.
- NeoGenomics, Inc. excess tax benefit from share-based compensation, operating activities for fiscal 2015 was $0.00.
| Period end | Excess Tax Benefit from Share-based Compensation, Operating Activities 12 month |
|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-03-13 |
| 2016-12-31 | $0.00 10-K · filed 2018-03-13 |
| 2015-12-31 | $0.00 10-K · filed 2018-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |